COVID-19 tracker: HDT Bio sues Emcure for alleged technology theft; CanSino gains booster nod in Malaysianews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: Aerium antibodies neutralize omincron and BA.2; Aspirin may help patients survive after infectionnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: AZ’s Evusheld nears EU green light; Fosun gears up to make generic antiviralsnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: GSK, Vir and more eye long COVID studiesnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: Cost watchdog ICER endorses Pfizer, Merck antiviral pricingnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: Biden rolls out pandemic preparedness budget; 2nd booster EUAs arrivenews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: J&J recipients should get mRNA booster, CDC saysnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: NIH starts trial of 2nd booster dose; FDA places more limits on GSK, Vir antibodiesnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: Merck’s pill helps patients clear virus faster than placebonews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: Roche’s Actemra in FDA fast lane for full approval; Debate over boosters lingersnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
